Skip to content

Clinical trials

Phase 3 Heart Failure trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Australia Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20051
20062
20072
20082
20121
20131
20143
20161
20175
20184
20201
20221
20231
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting7
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
AstraZeneca4
Novo Nordisk A/S3
Amgen2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2
Novartis Pharmaceuticals2
Abbott1
American Regent, Inc.1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure36
Stroke3
Cardiovascular Diseases2
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Obesity2
Renal Insufficiency2
Renal Insufficiency, Chronic2
Respiratory Insufficiency2
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.